Advertisement

Primary therapy of medulloblastoma with surgery, radiation and methotrexate and BCNU — A pilot study

  • Shiao Y. Woo
  • David McCullough
  • Lucius F. Sinks

Abstract

From 1976 to 1981, 15 patients, aged 2½ to 22 years, with histologically proven medulloblastoma were treated in a pilot study with surgical resection, craniospinal irradiation and one year of adjuvant chemotherapy with intermediate dose methotrexate (500mg/m2) and BCNU (100 mg/m2). Nine out of 15 patients (60%) are disease-free 27 months to 84 months (median 41 months) from diagnosis. Six patients relapsed at 7, 17, 19, 27, 28, and 31 months and they all died from disease. The degree of initial surgical resection is of prognostic importance. Six out of 7 patients (86%) who had grossly complete resection are alive without disease at 39 to 84 months (median 53 months) from diagnosis, whereas only 3 out of 8 patients (38%) who had incomplete resection of tumor are disease-free at 27, 39, and 83 months from diagnosis (p(2) = 0.07, Cox Mantel test). The chemotherapy was well tolerated without major toxicity (in particular leukoencephalopathy). Intermediate dose methotrexate appears to be a suitable agent for future preradiotherapy chemotherapy trials for medulloblastoma, especially for those patients at high risk for relapse.

Key words

medulloblastoma surgery craniospinal irradiation methotrexate BCNU 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Kramer S: Radiation therapy in the management of brain tumors in children. Ann NY Acad Sci 159: 571, 1969CrossRefGoogle Scholar
  2. 2.
    Harisiadis L, Chang CH: Medulloblastoma in children: a correlation between staging and results of treatment. Int J Rad Oncol Biol Phys 2: 833–841, 1977CrossRefGoogle Scholar
  3. 3.
    Mealey J Jr, Hall PV: Medulloblastoma in children. Survival and treatment. J Neurosurg 46: 56, 1977PubMedCrossRefGoogle Scholar
  4. 4.
    Lampkin BC, Mauer AM, McBride BH: Response of medulloblastoma to vincristine sulfate: a case report. Pediatrics 39: 761, 1967PubMedGoogle Scholar
  5. 5.
    Crist WM, Ragab AH, Vietti T, Ducos R, Chu JY: Chemotherapy in childhood medulloblastoma. Am J Dis Child 130: 639, 1976PubMedGoogle Scholar
  6. 6.
    Rosen G, Ghavimi F, Nirenberg A, Mosende C, Mehta BM: High-dose methotrexate with citrovorum factor rescue for the management of central nervous system tumors children. Cancer Treatment Reports 61: 681, 1977PubMedGoogle Scholar
  7. 7.
    Walker MD, Hurwitz BS: BCNU in the treatment of malignant brain tumors — A preliminary report. Cancer Chemo Rep 54: 263, 1970Google Scholar
  8. 8.
    Wilson CB, Boldrey EB, Enot JK: l,3-Bis(2-chloroethyl)l-nitrosourea (NSC 409962) in the treatment of brain tumors. Cancer Chemo Rep 54: 273, 1970Google Scholar
  9. 9.
    Fewer D, Wilson CB, Boldrey EB, Enot JK, Powell MR: The chemotherapy of brain tumors: clinical experience with carmustine (BCNU) and vincristine. JAMA 222: 549, 1972PubMedCrossRefGoogle Scholar
  10. 10.
    Fewer D, Wilson CB, Boldrey EB, Enot JK: Phase II study of CCNU in the treatment of brain tumors. Cancer Chemo Rep 56: 421, 1972Google Scholar
  11. 11.
    Kumar ARV, Renaudin J, Wilson CB, Boldrey EB, Enot JK, Levin VA: Procarbazine hydrochloride in the treatment of brain tumors: phase 2 study. J Neurosurg 40: 365, 1974CrossRefGoogle Scholar
  12. 12.
    Sklansky BD, Mann-Kaplan RS, Reynolds AF Jr, Rosenblum ML, Walker MD: ′-demethylepipodophyllotoxin-B-D-thenylidene-glucoside (PTG) in the treatment of malignant intracranial neoplasms. Cancer 33: 460, 1974PubMedCrossRefGoogle Scholar
  13. 13.
    Bloom HJG: Intracranial tumors: response and resistance to therapeutic endeavors, 1970–1980. Int J Rad Oncol Biol Phys 8: 1083, 1982Google Scholar
  14. 14.
    Bloom HFJ, Thornton-Jones H: Adjuvant chemotherapy for medulloblastoma: the multicenter controlled trial of the International Society of Pediatric Oncology (SIOP), 13th International Congress of Chemotherapy, 1983Google Scholar
  15. 15.
    Data presented at AROCC Symposium on Controversies of Cancer in Children and Adolescents, September 1981Google Scholar

Copyright information

© Martinas Nijhoff Publishers, Boston 1986

Authors and Affiliations

  • Shiao Y. Woo
    • 1
    • 2
    • 3
  • David McCullough
    • 1
    • 2
    • 3
  • Lucius F. Sinks
    • 1
    • 2
    • 3
  1. 1.Tufts University School of Medicine and New England Medical Center HospitalsBostonUSA
  2. 2.Department of NeurosurgeryChildren’s Hospital National Medical CenterWashingtonUSA
  3. 3.Cancer Center BranchNational Institutes of HealthBethesdaUSA

Personalised recommendations